These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38582812)

  • 1. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome.
    Mathieson L; Koppensteiner L; Dorward DA; O'Connor RA; Akram AR
    Br J Cancer; 2024 May; 130(11):1758-1769. PubMed ID: 38582812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy.
    Kraxner A; Braun F; Cheng WY; Yang TO; Pipaliya S; Canamero M; Andersson E; Harring SV; Dziadek S; Bröske AE; Ceppi M; Tanos T; Teichgräber V; Charo J
    Front Immunol; 2024; 15():1352632. PubMed ID: 39035007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY; Yeo SY; Xuan YH; Kim SH
    PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
    Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
    Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
    Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
    Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
    Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
    J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining the optimal CAF cluster marker for predicting TME-dependent survival expectancy and treatment benefits in NSCLC patients.
    Li K; Wang R; Liu GW; Peng ZY; Wang JC; Xiao GD; Tang SC; Du N; Zhang J; Zhang J; Ren H; Sun X; Yang YP; Liu DP
    Sci Rep; 2024 Jul; 14(1):16766. PubMed ID: 39034310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.
    Liao Y; Ni Y; He R; Liu W; Du J
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1523-8. PubMed ID: 23835897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
    Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
    BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of cancer-associated fibroblasts in the intratumoral stroma and invasive front in colorectal cancer.
    Son GM; Kwon MS; Shin DH; Shin N; Ryu D; Kang CD
    Medicine (Baltimore); 2019 May; 98(18):e15164. PubMed ID: 31045759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
    Kilvaer TK; Rakaee M; Hellevik T; Østman A; Strell C; Bremnes RM; Busund LT; Dønnem T; Martinez-Zubiaurre I
    PLoS One; 2018; 13(2):e0192157. PubMed ID: 29415055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
    Park CK; Jung WH; Koo JS
    Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma.
    Knuutila JS; Riihilä P; Nissinen L; Heiskanen L; Kallionpää RE; Pellinen T; Kähäri VM
    Int J Cancer; 2024 Sep; 155(6):1112-1127. PubMed ID: 38648387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma.
    Wong PF; Wei W; Gupta S; Smithy JW; Zelterman D; Kluger HM; Rimm DL
    J Immunother Cancer; 2019 Jul; 7(1):194. PubMed ID: 31337426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis.
    Zhao Y; Jia Y; Wang J; Chen X; Han J; Zhen S; Yin S; Lv W; Yu F; Wang J; Xu F; Zhao X; Liu L
    Mol Cancer; 2024 Mar; 23(1):47. PubMed ID: 38459511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
    Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
    Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein.
    Gallant JP; Hintz HM; Gunaratne GS; Breneman MT; Recchia EE; West JL; Ott KL; Heninger E; Jackson AE; Luo NY; Rosenkrans ZT; Hernandez R; Zhao SG; Lang JM; Meimetis L; Kosoff D; LeBeau AM
    Cancer Res Commun; 2024 Jun; 4(6):1481-1494. PubMed ID: 38747612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
    Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
    Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
    Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
    J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.